Cidara announced Thursday that it received a breakthrough therapy designation from the FDA for an investigational long-acting ...

Medical groups and state health departments are establishing their own vaccine recommendations in an effort to preserve ...

The ophthalmic industry recognized World Sight Day on Oct. 9 as it gathered in Boston for Academy 2025. Optometry Giving ...

The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

With AI moving at a fast pace, oculomics — the study of the eye as a window to systemic health — is expanding its potential ...

Adjustment procedures can help improve suboptimal results after implantation of corneal allogeneic intrastromal ring segments ...

The FDA has approved cemiplimab-rwlc for adjuvant treatment of adults with cutaneous squamous cell carcinoma at high risk for ...

Continuous glucose monitoring can be successfully initiated during hospitalization with training for hospital staff, robust ...

A long-term analysis of patients with early-stage non-small cell lung cancer showed those who received radiation achieved ...

Due to their critical role in health management, the nurse practitioner and physician assistant professions have consistently ...

Icotrokinra demonstrated superiority to placebo and deucravacitinib in the treatment of adults and adolescents with moderate ...